こはく酸メトプロロール の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D06542)
◆英語タイトル:Global Metoprolol Succinate Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D06542
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年12月7日(※2024年版があります。お問い合わせください。)
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、こはく酸メトプロロール の世界市場について調査・分析し、種類別には、25mg、50mg、100mg、200mgに、用途別には、高血圧、アンギナ、その他に区分してまとめました。調査対象企業は、Lannett、Hema Pharmaceuticals、Ravoos Laboratories Limited、Aralez、AstraZeneca、Tecoland、SURYA LIFE SCIENCES LTD.等です。

・レポートの概要
・グローバル成長トレンド
・こはく酸メトプロロール の世界市場規模
・こはく酸メトプロロール の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別こはく酸メトプロロール の価格動向
・こはく酸メトプロロール の種類別市場規模(25mg、50mg、100mg、200mg)
・こはく酸メトプロロール の用途別市場規模(高血圧、アンギナ、その他)
・こはく酸メトプロロール の北米市場(アメリカ、カナダ、メキシコ)
・こはく酸メトプロロール のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・こはく酸メトプロロール のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・こはく酸メトプロロール の中南米市場(ブラジル等)
・こはく酸メトプロロール の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Lannett、Hema Pharmaceuticals、Ravoos Laboratories Limited、Aralez、AstraZeneca、Tecoland、SURYA LIFE SCIENCES LTD.)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・こはく酸メトプロロール の市場規模予測
・こはく酸メトプロロール の種類別市場予測2018-2025(25mg、50mg、100mg、200mg)
・こはく酸メトプロロール の用途別市場予測2018-2025(高血圧、アンギナ、その他)
・こはく酸メトプロロール の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・こはく酸メトプロロール のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・こはく酸メトプロロール のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・こはく酸メトプロロール の中南米市場予測2018-2025(ブラジル等)
・こはく酸メトプロロール の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Metoprolol Succinate is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.APAC is expected to account for the largest share of application processor market during the forecast period.
In 2018, the global Metoprolol Succinate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Metoprolol Succinate.

This study researches the market size of Metoprolol Succinate, presents the global Metoprolol Succinate sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Metoprolol Succinate in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Metoprolol Succinate for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Lannett
Hema Pharmaceuticals
Ravoos Laboratories Limited
Aralez
AstraZeneca
Tecoland
SURYA LIFE SCIENCES LTD.

Market Segment by Product Type
25mg
50mg
100mg
200mg

Market Segment by Application
Hypertension
Angina
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Metoprolol Succinate status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Metoprolol Succinate manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Metoprolol Succinate are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Metoprolol Succinate Market Size Growth Rate by Type
1.3.2 25mg
1.3.3 50mg
1.3.4 100mg
1.3.5 200mg
1.4 Market Segment by Application
1.4.1 Global Metoprolol Succinate Market Share by Application (2018-2025)
1.4.2 Hypertension
1.4.3 Angina
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Metoprolol Succinate Market Size
2.1.1 Global Metoprolol Succinate Revenue 2013-2025
2.1.2 Global Metoprolol Succinate Sales 2013-2025
2.2 Metoprolol Succinate Growth Rate by Regions
2.2.1 Global Metoprolol Succinate Sales by Regions 2013-2018
2.2.2 Global Metoprolol Succinate Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Metoprolol Succinate Sales by Manufacturers
3.1.1 Metoprolol Succinate Sales by Manufacturers 2013-2018
3.1.2 Metoprolol Succinate Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Metoprolol Succinate Revenue by Manufacturers (2013-2018)
3.2.2 Metoprolol Succinate Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Metoprolol Succinate Market Concentration Ratio (CR5 and HHI)
3.3 Metoprolol Succinate Price by Manufacturers
3.4 Key Manufacturers Metoprolol Succinate Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Metoprolol Succinate Market
3.6 Key Manufacturers Metoprolol Succinate Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 25mg Sales and Revenue (2013-2018)
4.1.2 50mg Sales and Revenue (2013-2018)
4.1.3 100mg Sales and Revenue (2013-2018)
4.1.4 200mg Sales and Revenue (2013-2018)
4.2 Global Metoprolol Succinate Sales Market Share by Type
4.3 Global Metoprolol Succinate Revenue Market Share by Type
4.4 Metoprolol Succinate Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Metoprolol Succinate Sales by Application

6 North America
6.1 North America Metoprolol Succinate Breakdown Data by Company
6.2 North America Metoprolol Succinate Breakdown Data by Type
6.3 North America Metoprolol Succinate Breakdown Data by Application
6.4 North America Metoprolol Succinate Breakdown Data by Countries
6.4.1 North America Metoprolol Succinate Sales by Countries
6.4.2 North America Metoprolol Succinate Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Metoprolol Succinate Breakdown Data by Company
7.2 Europe Metoprolol Succinate Breakdown Data by Type
7.3 Europe Metoprolol Succinate Breakdown Data by Application
7.4 Europe Metoprolol Succinate Breakdown Data by Countries
7.4.1 Europe Metoprolol Succinate Sales by Countries
7.4.2 Europe Metoprolol Succinate Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Metoprolol Succinate Breakdown Data by Company
8.2 Asia Pacific Metoprolol Succinate Breakdown Data by Type
8.3 Asia Pacific Metoprolol Succinate Breakdown Data by Application
8.4 Asia Pacific Metoprolol Succinate Breakdown Data by Countries
8.4.1 Asia Pacific Metoprolol Succinate Sales by Countries
8.4.2 Asia Pacific Metoprolol Succinate Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Metoprolol Succinate Breakdown Data by Company
9.2 Central & South America Metoprolol Succinate Breakdown Data by Type
9.3 Central & South America Metoprolol Succinate Breakdown Data by Application
9.4 Central & South America Metoprolol Succinate Breakdown Data by Countries
9.4.1 Central & South America Metoprolol Succinate Sales by Countries
9.4.2 Central & South America Metoprolol Succinate Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Metoprolol Succinate Breakdown Data by Type
10.2 Middle East and Africa Metoprolol Succinate Breakdown Data by Application
10.3 Middle East and Africa Metoprolol Succinate Breakdown Data by Countries
10.3.1 Middle East and Africa Metoprolol Succinate Sales by Countries
10.3.2 Middle East and Africa Metoprolol Succinate Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Lannett
11.1.1 Lannett Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.1.4 Metoprolol Succinate Product Introduction
11.1.5 Lannett Recent Development
11.2 Hema Pharmaceuticals
11.2.1 Hema Pharmaceuticals Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.2.4 Metoprolol Succinate Product Introduction
11.2.5 Hema Pharmaceuticals Recent Development
11.3 Ravoos Laboratories Limited
11.3.1 Ravoos Laboratories Limited Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.3.4 Metoprolol Succinate Product Introduction
11.3.5 Ravoos Laboratories Limited Recent Development
11.4 Aralez
11.4.1 Aralez Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.4.4 Metoprolol Succinate Product Introduction
11.4.5 Aralez Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.5.4 Metoprolol Succinate Product Introduction
11.5.5 AstraZeneca Recent Development
11.6 Tecoland
11.6.1 Tecoland Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.6.4 Metoprolol Succinate Product Introduction
11.6.5 Tecoland Recent Development
11.7 SURYA LIFE SCIENCES LTD.
11.7.1 SURYA LIFE SCIENCES LTD. Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Metoprolol Succinate
11.7.4 Metoprolol Succinate Product Introduction
11.7.5 SURYA LIFE SCIENCES LTD. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Metoprolol Succinate Sales Channels
12.2.2 Metoprolol Succinate Distributors
12.3 Metoprolol Succinate Customers

13 Market Forecast
13.1 Global Metoprolol Succinate Sales and Revenue Forecast 2018-2025
13.2 Global Metoprolol Succinate Sales Forecast by Type
13.3 Global Metoprolol Succinate Sales Forecast by Application
13.4 Metoprolol Succinate Forecast by Regions
13.4.1 Global Metoprolol Succinate Sales Forecast by Regions 2018-2025
13.4.2 Global Metoprolol Succinate Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Metoprolol Succinate Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Metoprolol Succinate Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Metoprolol Succinate Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Metoprolol Succinate Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Metoprolol Succinate Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Lannett、Hema Pharmaceuticals、Ravoos Laboratories Limited、Aralez、AstraZeneca、Tecoland、SURYA LIFE SCIENCES LTD.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ こはく酸メトプロロール の世界市場動向・分析2018-2025(Global Metoprolol Succinate Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。